Inventor
SIN NY
US28 patents
⚠️ This page may combine multiple inventors who share the name “SIN NY”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BRISTOL MYERS SQUIBB CO
16 patentsUS7449479B2Nov 11, 2008
Hepatitis C virus inhibitors
BRISTOL MYERS SQUIBB CO67 citations99
US6995174B2Feb 7, 2006
Hepatitis C virus inhibitors
BRISTOL MYERS SQUIBB CO194 citations98
US7135462B2Nov 14, 2006
Hepatitis C virus inhibitors
BRISTOL MYERS SQUIBB CO72 citations97
US7041698B2May 9, 2006
Hepatitis C virus inhibitors
BRISTOL MYERS SQUIBB CO135 citations97
US7915291B2Mar 29, 2011
Hepatitis C virus inhibitors
BRISTOL MYERS SQUIBB CO40 citations96
US8710229B2Apr 29, 2014
Hepatitis C virus inhibitors
BRISTOL MYERS SQUIBB CO10 citations92
US7323447B2Jan 29, 2008
Hepatitis C virus inhibitors
BRISTOL MYERS SQUIBB CO50 citations92
US6489338B2Dec 3, 2002
Imidazopyridine and imidazopyrimidine antiviral agents
BRISTOL MYERS SQUIBB CO25 citations91
US9227940B2Jan 5, 2016
Hepatitis C virus inhibitors
BRISTOL MYERS SQUIBB CO3 citations84
US7772180B2Aug 10, 2010
Hepatitis C virus inhibitors
BRISTOL MYERS SQUIBB CO17 citations84
US8889871B2Nov 18, 2014
Hepatitis C virus inhibitors
BRISTOL MYERS SQUIBB CO3 citations74
US9636375B2May 2, 2017
Hepatitis C virus inhibitors
BRISTOL MYERS SQUIBB CO1 citations63
US7592336B2Sep 22, 2009
Hepatitis C virus inhibitors
BRISTOL MYERS SQUIBB CO4 citations62
US6774134B2Aug 10, 2004
Heterocyclic substituted 2-methyl-benzimidazole antiviral agents
BRISTOL MYERS SQUIBB CO5 citations61
US8889854B2Nov 18, 2014
C-17 bicyclic amines of triterpenoids with HIV maturation inhibitory activity
BRISTOL MYERS SQUIBB CO1 citations52
US6844342B2Jan 18, 2005
Heterocyclic substituted 2-methyl-benzimidazole antiviral agents
BRISTOL MYERS SQUIBB CO0 citations50
REGUEIRO-REN ALICIA
3 patentsUS8846647B2Sep 30, 2014
C-17 and C-3 modified triterpenoids with HIV maturation inhibitory activity
REGUEIRO-REN ALICIA19 citations83
US8802661B2Aug 12, 2014
C-28 amides of modified C-3 betulinic acid derivatives as HIV maturation inhibitors
REGUEIRO-REN ALICIA14 citations83
US8754068B2Jun 17, 2014
Modified C-3 betulinic acid derivatives as HIV maturation inhibitors
REGUEIRO-REN ALICIA15 citations83
VIIV HEALTHCARE UK NO 5 LTD
3 patentsUS11084845B2Aug 10, 2021
C-3 and C-17 modified triterpenoids as HIV-1 inhibitors
VIIV HEALTHCARE UK NO 5 LTD1 citations62
US10421774B2Sep 24, 2019
C-3 and C-17 modified triterpenoids as HIV-1 inhibitors
VIIV HEALTHCARE UK NO 5 LTD1 citations62
US10047118B2Aug 14, 2018
C17-aryl substituted betulinic acid analogs
VIIV HEALTHCARE UK NO 5 LTD0 citations42